Suppr超能文献

给予一种在DNA合成阶段抑制肿瘤细胞分裂的细胞毒性药物后大鼠骨骼系统的变化及其消退情况。

Changes and their regression in the osseous system in rats after administering a cytostatic drug inhibiting tumor cell division in the phase of DNA synthesis.

作者信息

Cegieła Urszula, Pytlik Maria, Janiec Waldemar

机构信息

Department of Pharmacology, Silesian Medical University, Jagiellońska 4, PL 41-200 Sosnowiec, Poland.

出版信息

Pol J Pharmacol. 2004 Nov-Dec;56(6):805-16.

Abstract

Chemotherapeutic drugs may disturb the bone tissue metabolism and cause osteopenia, however, the pathomechanism of the damaging effect of cytostatics on this tissue has not been well recognized so far. The detrimental effect may result from a direct cytotoxic action of these drugs on cells remodeling the bone, or on osteogenic cells present in the bone and in the bone marrow, or may be the result of hormonal disorder caused by impaired function of gonads. The aim of this study was to investigate the in vivo effect of 5-fluorouracil (5-FU), a cytostatic agent which inhibits tumor cell division in the phase of DNA synthesis, on the bone remodeling in rats and to examine whether the period of 4 weeks was sufficient for regression of changes elicited by administering 5-FU. Changes in the bone tissue following administration of 5-FU and their regression were evaluated by assessing macrometric and histomorphometric parameters as well as of mechanical properties of the femur. The tests were carried out on male Wistar rats. 5-FU was administered at the doses: 30 mg/kg per os (po) daily for 5 days every 2 weeks; 15 mg/kg im daily for 5 days every 2 weeks; 65 mg/kg im once weekly. Changes in the osseous tissue were examined 4 weeks after the first dose of 5-FU administration. Regression of the changes was examined 8 weeks after the first dose of 5-FU administration (the 5-FU was not administered between 30th and 57th day after the first dose of 5-FU administration). As a result of our research, it was established that 5-FU disturbed the bone remodeling processes in rats, mostly by impairing the process of new bone matrix synthesis, which leads to impaired mineralization process and decreased mechanical endurance of the femur. It was also established that the period of 4 weeks was not sufficient for regression of the changes in the osseous tissue caused by 5-FU administration.

摘要

化疗药物可能会扰乱骨组织代谢并导致骨质减少,然而,目前细胞毒性药物对该组织的损伤作用的发病机制尚未得到充分认识。这种有害作用可能源于这些药物对重塑骨骼的细胞或存在于骨骼和骨髓中的成骨细胞的直接细胞毒性作用,也可能是性腺功能受损导致的激素紊乱的结果。本研究的目的是研究5-氟尿嘧啶(5-FU),一种在DNA合成阶段抑制肿瘤细胞分裂的细胞毒性药物,对大鼠骨重塑的体内作用,并检查4周时间是否足以使5-FU给药引起的变化消退。通过评估宏观和组织形态学参数以及股骨的力学性能来评估5-FU给药后骨组织的变化及其消退情况。实验在雄性Wistar大鼠身上进行。5-FU的给药剂量为:每2周口服(po)30mg/kg,每日1次,共5天;每2周肌肉注射(im)15mg/kg,每日1次,共5天;每周肌肉注射1次65mg/kg。在首次给予5-FU后4周检查骨组织的变化。在首次给予5-FU后8周检查变化的消退情况(在首次给予5-FU后的第30天至第57天之间未给予5-FU)。我们的研究结果表明,5-FU扰乱了大鼠的骨重塑过程,主要是通过损害新骨基质合成过程,这导致矿化过程受损和股骨机械耐力下降。还确定4周时间不足以使5-FU给药引起的骨组织变化消退。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验